Navigation Links
New Bacterium Discovered - Related to Cause of Trench Fever

A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation. The woman, who has since recovered, suffered from symptoms similar to malaria or typhoid fever, two infections that can occur in returning travelers.

But genetic detective work revealed that she was infected with a new bacterium that had never before been isolated from a human.

A UCSF infectious disease team, in collaboration with colleagues from other institutions, found that the new microbe is genetically similar to one spread by body lice in the trenches during World War I. That bacterium, called Bartonella quintana, caused a disease known as trench fever, and debilitated tens of thousands of soldiers with severe leg and back pain and recurrent fevers.

The new species, recently named Bartonella rochalimae, is also closely related to the bacterium identified about 10 years ago as the cause of cat scratch disease: Bartonella henselae, which infects more than 25,000 people a year in the U.S.

The woman had been traveling in the Peruvian Andes. She suffered from potentially life-threatening anemia, an enlarged spleen and a high fever for several weeks, as do victims of malaria and typhoid. The Andes are also home to another Bartonella species, spread by sand flies. The researchers first thought this was causing the patients infection.

But genetic comparisons showed that although the new bacterium is related enough to be classified with the other Bartonella bacteria, it is nevertheless distinct from all of them, the UCSF team found. The UCSF lab is one of the few in the world able to isolate and grow human Bartonella species, and culture of the new organism made study of the DNA much easier.

Also collaborating on the research were scientists at the Massachusetts General Hospital of Harvard Medical School and the Centers
'"/>




Page: 1 2 3 4

Related medicine news :

1. Pig Bacterium (Streptococcus suis) Kills 24 In China
2. Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium
3. Streptococcus Bacterium Enzyme Identified
4. Bacterium Overtook Patients At Brisbane Women’s Hospita
5. Cell-Wall Carbohydrate in Anthrax Bacterium Holds Promise for New Vaccines
6. Clues Found On How Deadly Bacterium Gains Foothold
7. Bacterium Could Treat PCBs Without the Need for Dredging
8. Exposure to a Soil Bacterium can Boost Happiness
9. Exposure to a Soil Bacterium can Boost Happiness
10. Genome of Botulism Bacterium Revealed
11. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
Post Your Comments:
Breaking Medicine News(10 mins):Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 3Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 4Health News:Pharmacists Encourage Consumers to Practice Safe Medication Storage and Disposal 2Health News:Pharmacists Encourage Consumers to Practice Safe Medication Storage and Disposal 3Health News:Aurora Health Care and ECRS Complete 112 Location Retail Automation Project 2Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 2Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 3Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 4Health News:Surgical quality program is a strong tool for assessing outcomes for high-risk procedures 2
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 1New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 2New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 3New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 4Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 1Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 2Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 3Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 1Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 2Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 3